BioTime公司今日早前宣布计划收购一家新加坡私营有限责任公司胚胎干细胞国际公司（ES Cell International Pte Ltd，ESI）。BioTime在今日早前公布的新闻发布中表示，公司将"收购ESI的全部约3500万美元债款及应计利息。除BioTime在收购完成后将要承担的偿付义务之外，ESI不 ...

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on addressing degenerative diseases, announced today the submission of a design ...

ALAMEDA, Calif.--BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today announced it has submitted a Clinical ...

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, has licensed one of its pluripotent cell lines to Goliver ...

BEND, OR / ACCESSWIRE / September 22, 2017 / BioTime, Inc. (NASDAQ: BTX), Sylva International has always been extremely interested in regenerative medicines because they've shown tremendous promise in ...

BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that on May 1, 2014, the Company received approximately ...

A look at the shareholders of BioTime Inc (NYSEMKT:BTX) can tell us which group is most powerful. Institutions will often hold stock in bigger companies, and we expect to see insiders owning a ...

ALAMEDA, Calif. & MENLO PARK, Calif.--BioTime, Inc. (NYSE MKT: BTX) announced today that its subsidiary Asterias Biotherapeutics, Inc. ("Asterias"), has raised $12.5 million through the sale of ...

BioTime Inc. picked up 400 patents and applications plus other intellectual property dealing with human embryonic stem cells from Geron Inc. BioTime Inc. picked up 400 patents and applications plus ...

Stem cell technology developer Cell Targeting has sold its assets to BioTime (AMEX:BTX) in a deal worth about $2.3 million. BioTime will pay $250,000 in cash as well as 262,000 shares of BioTime’s ...

BioTime, Inc.BTX was a big mover last session, as the company saw its shares rise above 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session.

One stock that might be an intriguing choice for investors right now is BioTime, Inc.BTX. This is because this security in the Medical-Biomedical/Genetics space is seeing solid earnings estimate ...